[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_19159 

# __Enteric involvement in hospitalised patients with covid-19__

## Articles mentionning the risk

* [Lodder_sars-cov-2_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_666.md)

## Mitigations of this risk

* [Regular monitoring and testing of gastrointestinal symptoms in covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_21132.md)

## Name of the risk

Potential for gastrointestinal symptoms in patients with COVID-19

## People affected by this risk

* [Hospital medical staff](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5550.md)
* [Patients with covid-19](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_14861.md)

## Stakeholders who can mitigate this risk

* [Medical institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_0.md)
* [Public health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3423.md)

## Technologies linked to the risk

* [Diagnostic testing for sars-cov-2 rna in stool samples](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_21484.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Poor access to diagnostics and treatment](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_41.md)

